Intelligent Systems and Inflammatory Bowel Disease: Exploring the Potential for Outpatient Support
This talk outlines the findings from research which seeks to understand how AI and ML have been applied to the realm of patient care within the context of chronic disease, with a specific focus on Inflammatory Bowel Disease (IBD).
a death sentence, but it can often be a life sentence. [..] For patients and their families, the impact of a chronic disease will bring changes in their personal, social and emotional lives.” Thomas, G (2008) Counselling and Reflexive Research in Healthcare : Working Therapeutically with Clients with Inflammatory Bowel Disease, Jessica Kingsley Publishers, London. The solution? Can advances in machine learning and artificial intelligence help tackle some of the challenges faced by those affected by IBD?
al. (2013) Artificial Neural Network (ANN) and a Probabilistic Neural Network (PNN) used to diagnose IBD. • 98.31% Rate of Accuracy. Prognosis: • Waljee et al. 2010 used Random Forest to analysis laboratory data to determine the success of thioprine treatment. Results: Area under Receiver Operating Characteristic (AUROC) curve of 0.856 vs AUROC of 0.594 from traditional testing techniques. • Hardalaç et al 2015 used ANN to determine the success of treating patients with the immunosuppressant drug Azathioprine. Taking into account patient health and lifestyle metrics. Results: predict the efficacy of Azathioprine use with a precision of 79%. Outpatient Support: ?????